They’ve been announcing “new variants” that “evade vaccines” for months now.
But eventually, one of these is going to stick, and they’re going to tell all of these vaxed cattle that their vax doesn’t work anymore, and it’s basically like they never got a vax, and now they have to wait for a completely new vax.
I said all of this before it even happened.
Not one of you readers should be surprised by any of it. Surely, I’ve got a good track record on this stuff.
The A.30 variant of the coronavirus, detected in Angola and Sweden, is highly resistant to antibodies induced by the Pfizer and AstraZeneca vaccines, a new lab study has shown.
A team from Germany looked at the rare A.30 variant that was first recorded in Tanzania and later detected in several patients in Angola and Sweden this spring. They compared the mutation to the Beta and Eta variants. Beta was chosen because it has “the highest level” of resistance to antibodies, the researchers said.
According to the study published in the peer-reviewed journal Cellular & Molecular Immunology this week, the A.30 variant showed improved ability to enter most host cells, including kidney, liver, and lung cells.
The mutation “enters certain cell lines with increased efficiency and evades antibody-mediated neutralization,” the study found.
“In summary, A.30 exhibits a cell line preference not observed for other viral variants and efficiently evades neutralization by antibodies elicited by ChAdOx1 nCoV-19 [AstraZeneca] or BNT162b2 [Pfizer] vaccination.”
The variant also proved to be resistant to monoclonal drug Bamlanivimab, which is used for Covid-19 treatment, but was vulnerable to a cocktail of Bamlanivimab and Etesevimab.
Maybe it will be “A.30” that eventually gets announced as making vaccines useless, or maybe it will be another one that they announce in the winter.
It doesn’t matter – it’s all fake anyway.
But eventually, The Science will declare that there is a new variant that totally negates the vaccines completely, which will mean the cattle are back to stage one.